| 1 | image description image description | | | | | | | 8 | 3.49% |
| 2 | description image description image | | | | | | | 8 | 3.49% |
| 3 | cgmp peptides peptide apis | | | | | | | 2 | 0.87% |
| 4 | dna synthesizers preparative hplc | | | | | | | 2 | 0.87% |
| 5 | a leading peptide and | | | | | | | 2 | 0.87% |
| 6 | instrumentation manufacturing company located | | | | | | | 2 | 0.87% |
| 7 | manufacturing company located in | | | | | | | 2 | 0.87% |
| 8 | company located in silicon | | | | | | | 2 | 0.87% |
| 9 | csbio is a leading | | | | | | | 2 | 0.87% |
| 10 | peptide synthesizers dna synthesizers | | | | | | | 2 | 0.87% |
| 11 | located in silicon valley | | | | | | | 2 | 0.87% |
| 12 | is a leading peptide | | | | | | | 2 | 0.87% |
| 13 | description our productsservices peptides | | | | | | | 1 | 0.44% |
| 14 | our productsservices peptides peptides | | | | | | | 1 | 0.44% |
| 15 | productsservices peptides peptides from | | | | | | | 1 | 0.44% |
| 16 | nonclinical to commercial scale | | | | | | | 1 | 0.44% |
| 17 | image description our productsservices | | | | | | | 1 | 0.44% |
| 18 | commercial scale learn more | | | | | | | 1 | 0.44% |
| 19 | to commercial scale learn | | | | | | | 1 | 0.44% |
| 20 | purification equipment image description | | | | | | | 1 | 0.44% |
| 21 | scale learn more instrumentation | | | | | | | 1 | 0.44% |
| 22 | learn more instrumentation portfolio | | | | | | | 1 | 0.44% |
| 23 | of instruments that include | | | | | | | 1 | 0.44% |
| 24 | instruments that include peptide | | | | | | | 1 | 0.44% |
| 25 | that include peptide synthesizers | | | | | | | 1 | 0.44% |
| 26 | equipment image description image | | | | | | | 1 | 0.44% |
| 27 | process scale dna synthesizers | | | | | | | 1 | 0.44% |
| 28 | scale dna synthesizers preparative | | | | | | | 1 | 0.44% |
| 29 | peptides peptide apis nonclinical | | | | | | | 1 | 0.44% |
| 30 | team provides the best | | | | | | | 1 | 0.44% |
| 31 | provides the best in | | | | | | | 1 | 0.44% |
| 32 | the best in class | | | | | | | 1 | 0.44% |
| 33 | best in class products | | | | | | | 1 | 0.44% |
| 34 | in class products and | | | | | | | 1 | 0.44% |
| 35 | class products and services | | | | | | | 1 | 0.44% |
| 36 | products and services in | | | | | | | 1 | 0.44% |
| 37 | the industry cgmp peptides | | | | | | | 1 | 0.44% |
| 38 | industry cgmp peptides peptide | | | | | | | 1 | 0.44% |
| 39 | peptides commercial clinical nonclinical | | | | | | | 1 | 0.44% |
| 40 | peptide apis nonclinical peptides | | | | | | | 1 | 0.44% |